Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Jones

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Journal of Neuro-Oncology|June 21, 2023
<sup>18</sup>F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot studyMartin C Tom, Frank P DiFilippo, Stephen E Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancerStephen E Jones, Michael A Savin, Frankie Ann Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysisDuveken B Y Fontein, Caroline Seynaeve, Peyman Hadji, et al.
Nature Medicine|August 14, 2023
Cerebellar deep brain stimulation for chronic post-stroke motor rehabilitation: a phase I trialKenneth B Baker, Ela B Plow, Sean Nagel, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)Joanne L Blum, Patrick J Flynn, Greg Yothers, et al.
Frontiers in Aging Neuroscience|June 11, 2025
Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired <i>APOE</i> ε4 carriersStephen M Rao, Alexandria L Chorba, M J Helppi, et al.
Frontiers in Neurology|August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)Ellen M Mowry, Robert A Bermel, James R Williams, et al.
Neurology|December 28, 2020
7T Epilepsy Task Force Consensus Recommendations on the Use of 7T MRI in Clinical PracticeGiske Opheim, Anja van der Kolk, Karin Markenroth Bloch, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Journal of Neuro-Oncology|June 21, 2023
<sup>18</sup>F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot studyMartin C Tom, Frank P DiFilippo, Stephen E Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancerStephen E Jones, Michael A Savin, Frankie Ann Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysisDuveken B Y Fontein, Caroline Seynaeve, Peyman Hadji, et al.
Nature Medicine|August 14, 2023
Cerebellar deep brain stimulation for chronic post-stroke motor rehabilitation: a phase I trialKenneth B Baker, Ela B Plow, Sean Nagel, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)Joanne L Blum, Patrick J Flynn, Greg Yothers, et al.
Frontiers in Aging Neuroscience|June 11, 2025
Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired <i>APOE</i> ε4 carriersStephen M Rao, Alexandria L Chorba, M J Helppi, et al.
Frontiers in Neurology|August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)Ellen M Mowry, Robert A Bermel, James R Williams, et al.
Neurology|December 28, 2020
7T Epilepsy Task Force Consensus Recommendations on the Use of 7T MRI in Clinical PracticeGiske Opheim, Anja van der Kolk, Karin Markenroth Bloch, et al.
Pageof 13